---
title: "Shenzhen Bioeasy Biotechnology Co., Ltd. (300942.SZ)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300942.SZ.md"
symbol: "300942.SZ"
name: "Shenzhen Bioeasy Biotechnology Co., Ltd."
industry: "Health Care Supplies"
datetime: "2026-05-21T16:08:37.113Z"
locales:
  - [en](https://longbridge.com/en/quote/300942.SZ.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300942.SZ.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300942.SZ.md)
---

# Shenzhen Bioeasy Biotechnology Co., Ltd. (300942.SZ)

## Company Overview

Shenzhen Bioeasy Biotechnology Co., Ltd., together with its subsidiaries, provides rapid food testing reagents and instruments in China and internationally. The company offers test kits, including veterinary, melamine, mycotoxin, pesticide, adulteration, ATP, vitamin, and others; equipment, such as incubator, reader, suitcase lab, automatic pressers, and others; and materials comprising pretreatment column, certified reference, and quality control. It also provides specialized solutions, which include multi-mode precision detection, project plan for specialized equipment, AI-powered fully automated grain comprehensive testing workstation, digital food safety automatic detection, rapid testing laboratory, smart supervision, and comprehensive solution for rapid testing. In addition, the company offers software platforms, such as smart grain depot, traceability, orchard, datian, tea garden, and park project, as well as digital village project and agricultural and rural data projects.

| Item | Detail |
|------|--------|
| Industry | Health Care Supplies |
| Exchange | CN Market |
| Website | [www.bioeasy.com](https://www.bioeasy.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-21T04:30:14.000Z

**Overall: C (0.46)**

**Industry**: Health Care Supplies

| Metric | Value |
|--------|-------|
| Industry Ranking | 29 / 40 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 14.51% |  |
| Net Profit YoY | -67.29% |  |
| P/B Ratio | 3.58 |  |
| Dividend Ratio | 0.24% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 2971532762.33 |  |
| Revenue | 271008224.42 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 0.78% | D |
| Profit Margin | 2.52% | C |
| Gross Margin | 55.80% | B |
| Revenue YoY | 14.51% | B |
| Net Profit YoY | -67.29% | E |
| Total Assets YoY | 3.11% | C |
| Net Assets YoY | 3.82% | C |
| Cash Flow Margin | 816.41% | A |
| OCF YoY | 14.51% | B |
| Turnover | 0.19 | D |
| Gearing Ratio | 39.55% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Shenzhen Bioeasy Biotechnology Co., Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "14.51%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-67.29%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "3.58",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.24%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "2971532762.33",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "271008224.42",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "0.78%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "2.52%",
          "rating": "C"
        },
        {
          "name": "Gross Margin",
          "value": "55.80%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "14.51%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "-67.29%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "3.11%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "3.82%",
          "rating": "C"
        },
        {
          "name": "Cash Flow Margin",
          "value": "816.41%",
          "rating": "A"
        },
        {
          "name": "OCF YoY",
          "value": "14.51%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "0.19",
          "rating": "D"
        },
        {
          "name": "Gearing Ratio",
          "value": "39.55%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 421.09 | 32/40 | 217.56 | 169.70 | 124.34 |
| PB | 3.46 | 33/40 | 5.39 | 4.82 | 4.48 |
| PS (TTM) | 10.59 | 33/40 | 18.69 | 16.15 | 15.06 |
| Dividend Yield | 0.24% | 33/40 | 0.19% | 0.18% | 0.16% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Snibe (300832.SZ) | A | D | C | A | C | B |
| 02 | Winner Medical (300888.SZ) | B | B | B | B | B | B |
| 03 | Fuerjia (301371.SZ) | B | C | D | A | B | B |
| 04 | MTM (688029.SH) | B | B | B | A | B | B |
| 05 | Endovastec (688016.SH) | A | B | D | A | B | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/300942.SZ/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/300942.SZ/norm.md)
- [Related News](https://longbridge.com/en/quote/300942.SZ/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/300942.SZ/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**